WASL · Western blot design guide

WASL Western Blot Planning Guide

Plan a WASL Western blot around the catalog-observed 54.8 kDa band, image-backed A05438-3 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for WASL (WASL): expected band 54.8 kDa, antibody A05438-3, and PMC-cited SDS-PAGE protocol steps
WASL Western blot protocol sheet — expected band 54.8 kDa, antibody A05438-3, controls and PMC citations. Open the full WASL WB guide →

WASL Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 54.8 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Breast
Negative control ⓘ Target knockdown/knockout
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 54.8 kDa
ⓘ Localization Cytoplasm, cytoskeleton / Nucleus
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated WASL Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAppendix
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA05438-3 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected WASL Western Blot Band Size?

Use the product-observed 54.8 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
54.8 kDaMatches the authoritative product WB observation.
54.8 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected WASL appearancePlan around 54.8 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band54.8 kDa; use this as the primary experimental expectation.
Calculated mass54.8 kDa from UniProt O00401; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A05438-3.
Why is my band missing or off?
SituationLikely causeNext action
54.8 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for WASL Western blot

🧪Use Breast as the first positive-control candidate; no defensible HPA Not detected tissue was available, so use a target knockdown/knockout negative control.
Positive control: Breast (High)
Negative control: Target knockdown/knockout
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for WASL

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Breast Reported tissue cells High Protein (HPA) HPA →
Cerebellum Reported tissue cells High Protein (HPA) HPA →
Caudate Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Section 3

Advanced WASL Western Blot Tips

Deeper troubleshooting and optimisation questions for WASL, answered from its protein features.

Which band should guide the blot?
Use 54.8 kDa, the observation attached to the authoritative A05438-3 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 54.8 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use a target knockdown/knockout control when no HPA Not detected tissue is available.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for WASL Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A05438-3 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC6904212, PMC11439846, PMC7460043.
Boster reagents

WASL Western Blot Reagents

Human/Mouse/Rat-reactive WASL Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for WASL using A05438-3; observed band 54.8 kDa
Anti-N WASP/WASL Antibody Picoband®
Cat # A05438-3

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.